Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients
Sara Ruiz‐Pinto, Guillermo Pita, Miguel Martín, et al.
Breast Cancer Research and Treatment (2017) Vol. 167, Iss. 1, pp. 249-256
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Frailty and aging in cancer survivors
Kirsten K. Ness, Matthew D. Wogksch
Translational research (2020) Vol. 221, pp. 65-82
Open Access | Times Cited: 84
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors
Smita Bhatia
JACC CardioOncology (2020) Vol. 2, Iss. 4, pp. 539-552
Open Access | Times Cited: 66
Molecular mechanisms of anthracycline cardiovascular toxicity
Anna Narezkina, Hari K. Narayan, Alice E. Zemljic‐Harpf
Clinical Science (2021) Vol. 135, Iss. 10, pp. 1311-1332
Closed Access | Times Cited: 43
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
Zeina N. Al-Mahayri, George P. Patrinos, Bassam R. Ali
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 37
Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?
Zeina N. Al-Mahayri, Mohammad M. AlAhmad, Bassam R. Ali
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 30
Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association
Thomas D. Ryan, James E. Bates, Karen E. Kinahan, et al.
Circulation (2025)
Closed Access
Architecture of The Human Ape1 Interactome Defines Novel Cancers Signatures
Dilara Ayyildiz, Giulia Antoniali, Chiara D’Ambrosio, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML
Nan Jiang, Xinzhuo Zhang, Qi Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy
Lanlan Tang, Wei Zhang, Yang Zhang, et al.
International Journal of Clinical Practice (2024) Vol. 2024, pp. 1-25
Open Access | Times Cited: 3
hiPSCs in cardio-oncology: deciphering the genomics
Emily Pinheiro, K. Ashley Fetterman, Paul W. Burridge
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 935-948
Open Access | Times Cited: 24
Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
Xinyu Yang, Guoping Li, Tao Yang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 22
Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
Irene Cartas Espinel, Marcelino Telechea‐Fernández, Carlos Manterola, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 3, pp. 1651-1665
Open Access | Times Cited: 13
Exploring Aerobic Energy Metabolism in Breast Cancer: A Mutational Profile of Glycolysis and Oxidative Phosphorylation
Ricardo Cunha de Oliveira, Giovanna C. Cavalcante, Giordano B. Soares‐Souza
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12585-12585
Open Access | Times Cited: 2
Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies
Nhan Nguyen, Terezinha Souza, Marcha Verheijen, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 17
Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review
Evelien G. E. Hurkmans, Annouk C. A. M. Brand, Job A.J. Verdonschot, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
Swetha Balaji, Antu K. Antony, Harry Tonchev, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2286-2286
Open Access | Times Cited: 6
Characterizing age-related changes in intact mitochondrial proteoforms in murine hearts using quantitative top-down proteomics
Andrea Ramírez‐Sagredo, Anju Teresa Sunny, Kellye A. Cupp‐Sutton, et al.
Clinical Proteomics (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy
Maria Lagou, Dimitra P. Anastasiadou, George S. Karagiannis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis
Xinyu Yang, Guoping Li, Manke Guan, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 14
The genetic underpinnings of anthracycline‐induced cardiomyopathy predisposition
Amy M. Berkman, Michelle A.T. Hildebrandt, Andrew P. Landstrom
Clinical Genetics (2021) Vol. 100, Iss. 2, pp. 132-143
Open Access | Times Cited: 13
Identification of potential biomarkers for predicting the early onset of diabetic cardiomyopathy in a mouse model
Rabia Johnson, Xolisa Nxele, Martin Cour, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Characterizing Age-related Changes in Intact Mitochondrial Proteoforms in Murine Hearts using Quantitative Top-Down Proteomics
Andrea Ramírez‐Sagredo, Anju Teresa Sunny, Kellye A. Cupp‐Sutton, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Timothy N. McOwan, Lauren Craig, Anne Tripdayonis, et al.
Cardio-Oncology (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 11
POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
Alejandro Velasco-Ruíz, Rocío Núñez‐Torres, Guillermo Pita, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1942-1942
Open Access | Times Cited: 10
Relationship Between Mitochondrial Biological Function and Breast Cancer
Shichen Miao, Qichao Ni, Jun Fang
The Breast Journal (2024) Vol. 2024, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top